×
NexGel EBIT 2021-2024 | NXGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
NexGel ebit from 2021 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
NexGel EBIT 2021-2024 | NXGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
NexGel ebit from 2021 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$212.5B
Intuitive Surgical (ISRG)
$180.7B
Alcon (ALC)
$45.5B
Edwards Lifesciences (EW)
$40B
IQVIA Holdings (IQV)
$38.1B
IDEXX Laboratories (IDXX)
$33.9B
DexCom (DXCM)
$27.2B
Waters (WAT)
$23B
STERIS (STE)
$22.3B
SONOVA HOLDING (SONVY)
$22B
Hologic (HOLX)
$19.4B
Fresenius Medical Care AG KGaA (FMS)
$11.8B
Sysmex ADR (SSMXY)
$11.6B
Globus Medical (GMED)
$10.1B
Teleflex (TFX)
$9.6B
Penumbra (PEN)
$8.8B
Masimo (MASI)
$7.8B
Glaukos (GKOS)
$7.2B
PROCEPT BioRobotics (PRCT)
$5.1B
Integer Holdings (ITGR)
$4.2B
Inari Medical (NARI)
$2.9B
TransMedics (TMDX)
$2.9B
Veracyte (VCYT)
$2.7B
LivaNova (LIVN)
$2.7B
Nihon Kohden (NHNKY)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.2B
RxSight (RXST)
$1.9B
Integra LifeSciences Holdings (IART)
$1.9B
Alphatec Holdings (ATEC)
$1.2B